Table 4. Clinical outcomes in the patients.
| Clinical outcomes | LVT group, n=25 | Control group, n=242 | P |
|---|---|---|---|
| During hospitalization | |||
| MACCE | 6 (24.00%) | 9 (3.72%) | <0.01 |
| Death | 2 (8.00%) | 1 (0.41%) | <0.05 |
| Reoccurrence of MI | 0 (0.00%) | 1 (0.41%) | 0.91 |
| TVR | 0 (0.00%) | 1 (0.41%) | 0.91 |
| Stroke | 4 (16.00%) | 6 (2.48%) | <0.01 |
| Ischemic | 2 (8.00%) | 3 (1.24%) | <0.05 |
| Hemorrhagic | 2 (8.00%) | 3 (1.24%) | <0.05 |
| One-year follow-up | |||
| MACCE | 12 (48.00%) | 14 (5.79%) | <0.01 |
| Death | 3 (12.00%) | 2 (0.83%) | <0.01 |
| Reoccurrence of MI | 1 (4.00%) | 2 (0.83%) | 0.26 |
| TVR | 1 (4.00%) | 2 (0.83%) | 0.26 |
| Stroke | 7 (28.00%) | 8 (3.31%) | <0.01 |
| Ischemic | 5 (20.00%) | 5 (2.07%) | <0.01 |
| Hemorrhagic | 2 (8.00%) | 3 (1.24%) | <0.05 |
| Echocardiography | |||
| LVEDD (mm) | 53.00±2.08 | 53.14±1.03 | 0.95 |
| LVESD (mm) | 38.40±2.36 | 42.17±1.56 | 0.18 |
| LVEF (%) | 38.31±2.05 | 38.20±0.35 | 0.94 |
| LV aneurysm | 13 (52.00%) | 23 (9.50%) | <0.01 |
MACCE, major adverse cardiovascular and cerebrovascular event; TVR, target vessel revascularization; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction.